EYA3 and depressive symptom measurement: A polymorphism inASMT, the last gene in the melatonin synthesis pathway, is associated with circadian phase delay and perhaps with inadequate melatonin synthesis (factors that combined might augment or inhibit EYA3), and with depression and bipolar disorder117,118.